Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 4/20 | 0.59 |
| ▸ | MAPT | P10636 | 3/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.57 |
| ▸ | TSHR | P16473 | 2/20 | 0.53 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.52 |
| ▸ | XIAP | P98170 | 1/20 | 0.52 |
| ▸ | HKDC1 | Q2TB90 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.52 |
| ▸ | MEN1 | O00255 | 5/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.51 |
| ▸ | TP53 | P04637 | 1/20 | 0.51 |
| ▸ | GLA | P06280 | 1/20 | 0.51 |
| ▸ | POLB | P06746 | 1/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.51 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.51 |
| ▸ | HPGD | P15428 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29774638 | 0.89 | ALOX15 (0.70) | ALOX15MAPTSMN1; SMN2KDM4ETSHR | |
| SCHEMBL824555 | 0.89 | ALOX15 (0.70) | ALOX15MAPTSMN1; SMN2KDM4ETSHR | |
| SCHEMBL845435 | 0.84 | ALOX15 (0.67) | ALOX15MAPTSMN1; SMN2KDM4ETSHR | |
| Potassium SCHEMBL30798831 | 0.84 | NPC1 (0.54) | ALOX15MAPTSMN1; SMN2KDM4EALDH1A1 | |
| SCHEMBL27173134 | 0.84 | MEN1 (0.48) | ALOX15MAPTSMN1; SMN2KDM4EALDH1A1 | |
| SCHEMBL27172845 | 0.84 | MEN1 (0.48) | ALOX15MAPTSMN1; SMN2KDM4ETSHR | |
| SCHEMBL27204924 | 0.84 | MEN1 (0.48) | ALOX15MAPTSMN1; SMN2KDM4ETSHR | |
| SCHEMBL12942069 | 0.83 | ALOX15 (0.54) | ALOX15MAPTSMN1; SMN2KDM4ETSHR | |
| SCHEMBL825646 | 0.83 | MAPT (0.80) | ALOX15MAPTSMN1; SMN2ALDH1A1L3MBTL1 | |
| SCHEMBL23704744 | 0.83 | ALOX15 (0.43) | ALOX15MAPTSMN1; SMN2KDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 141 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240251664-A1 | LIGHT EMITTING ELEMENT AND AMINE COMPOUND FOR THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2024-07-25 | — | — | US | claimed |
| CN-114113294-B | Online measuring device and method for determining yield strength and tensile strength of strip steel | 宝山钢铁股份有限公司 | 2023-12-12 | — | — | CN | claimed |
| CN-114113294-A | Online measuring device and method for determining yield strength and tensile strength of strip steel | 宝山钢铁股份有限公司 | 2022-03-01 | — | — | CN | claimed |
| US-20260150491-A1 | ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT | CANON KABUSHIKI KAISHA (JP) | 2026-05-28 | — | — | US | disclosed |
| EP-4750286-A1 | ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT | Canon Kabushiki Kaisha (JP) | 2026-05-27 | — | — | EP | disclosed |
| CN-122079730-A | Organic compound and organic light-emitting element | — | 2026-05-26 | — | — | CN | disclosed |
| CN-122055591-A | Docking station for a spectrometer and associated measurement method | 法国原子能源和替代能源委员会 | 2026-05-15 | — | — | CN | disclosed |
| US-20260136815-A1 | LIGHT EMITTING DEVICE, DISPLAY DEVICE, PHOTOELECTRIC CONVERSION DEVICE, ELECTRONIC APPARATUS, ILLUMINATION DEVICE, MOVING BODY, AND WEARABLE DEVICE | CANON KK (JP) | 2026-05-14 | — | — | US | disclosed |
| EP-4742869-A1 | LIGHT EMITTING DEVICE, DISPLAY DEVICE, PHOTOELECTRIC CONVERSION DEVICE, ELECTRONIC APPARATUS, ILLUMINATION DEVICE, MOVING BODY, AND WEARABLE DEVICE | Canon Kabushiki Kaisha (JP) | 2026-05-13 | — | — | EP | disclosed |
| CN-122028624-A | Light emitting device, display device, photoelectric conversion device, electronic apparatus, lighting device, mobile body, and wearable device | 佳能株式会社 | 2026-05-12 | — | — | CN | disclosed |
| US-20260090255-A1 | LIGHT EMITTING DEVICE, DISPLAY DEVICE, PHOTOELECTRIC CONVERSION DEVICE, ELECTRONIC APPARATUS, ILLUMINATION DEVICE, MOVING BODY, AND WEARABLE DEVICE | CANON KK (JP) | 2026-03-26 | — | — | US | disclosed |
| US-11251375-B2 | While organic EL element | CANON KABUSHIKI KAISHA (JP) | 2022-02-15 | — | — | US | disclosed |
| US-20200377512-A1 | SUBSTITUTED 1-OXO-ISOINDOLINE-5-CARBOXAMIDE COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF TREATMENT THEREWITH | SIGNAL PHARMACEUTICALS, LLC | 2020-12-03 | — | — | US | disclosed |
| WO-2020243379-A1 | SUBSTITUTED 1-OXO-ISOINDOLINE-5-CARBOXAMIDE COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF TREATMENT THEREWITH | CELGENE CORPORATION (US) | 2020-12-03 | — | — | WO | disclosed |
| US-8143283-B1 | Methods for treating blood-born tumors with thalidomide | THE CHILDREN'S MEDICAL CENTER CORPORATION (US) | 2012-03-27 | — | — | US | disclosed |
| US-7723361-B2 | Methods for inhibiting undesired angiogenesis in patients having tumors with thalidomide | CELGENE CORPORATION (US) | 2010-05-25 | — | — | US | disclosed |
| EP-1920773-A1 | Compositions for inhibition of anglogenesis | The Children's Medical Center Corporation (US) | 2008-05-14 | — | — | EP | disclosed |
| US-20080096952-A1 | Methods for the treatment of atherosclerosis, using substituted phenethylsulfones | CELGENE CORPORATION | 2008-04-24 | — | — | US | disclosed |
| US-20080096952-A1 | Methods for the treatment of atherosclerosis, using substituted phenethylsulfones | CELGENE CORPORATION | 2008-04-24 | — | — | US | disclosed |
| CN-1342146-A | Substituted 1-oxo-and 1, 3-dioxoisoindolines and their use in pharmaceutical compositions for reducing inflammatory cytokine levels | CELGENE CORP (US) | 2002-03-27 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200377512-A1 | SUBSTITUTED 1-OXO-ISOINDOLINE-5-CARBOXAMIDE COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF TREATMENT THEREWITH | CPT1A, GOT2, IDH2 | ALOX15 2551/4885MAPT 1392/4885SMN1; SMN2 474/4885 |
| US-20260150491-A1 | ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT | NR2E3, RORB, RORA | ALOX15 1527/4885MAPT 3519/4885SMN1; SMN2 2513/4885 |
| US-20260136815-A1 | LIGHT EMITTING DEVICE, DISPLAY DEVICE, PHOTOELECTRIC CONVERSION DEVICE, ELECTRONIC APPARATUS, ILLUMINATION DEVICE, MOVING BODY, AND WEARABLE DEVICE | L1CAM, LAGE3, EPHA4 | ALOX15 4171/4885MAPT 2330/4885SMN1; SMN2 1107/4885 |
| US-20260090255-A1 | LIGHT EMITTING DEVICE, DISPLAY DEVICE, PHOTOELECTRIC CONVERSION DEVICE, ELECTRONIC APPARATUS, ILLUMINATION DEVICE, MOVING BODY, AND WEARABLE DEVICE | L1CAM, DSP, LAGE3 | ALOX15 3755/4885MAPT 2006/4885SMN1; SMN2 1055/4885 |
| US-20080096952-A1 | Methods for the treatment of atherosclerosis, using substituted phenethylsulfones | TNF, TGFB1, TGFB2 | ALOX15 2059/4885MAPT 3273/4885SMN1; SMN2 3759/4885 |
| US-20240251664-A1 | LIGHT EMITTING ELEMENT AND AMINE COMPOUND FOR THE SAME | NES, NFE2L2, NUCB2 | ALOX15 2129/4885MAPT 1850/4885SMN1; SMN2 3377/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.